Viruses and VLPs are an important and growing component of biologics within the pharmaceutical industry, with important applications for gene therapy and vaccine development. These biologics present characterization challenges distinct from more traditional biotherapeutics, with the possible additional complication of a less well established regulatory environment. Malvern Panalytical has developed and refined specific technologies (NTA and DLS) to address issues of importance for this application, emphasizing low-cost and rapid technologies for the counting and sizing of particles. In addition, Malvern Panalytical offers a rapid, low volume and higher throughput approach to assessing thermal stability (automated DSC).

Presentations from current industrial users and from Malvern Panalytical scientists will emphasize the current capabilities of these technologies, as well as requirements for future development, with emphasis on practical applications and value addition throughout the development pipeline.

This is a free one-day event from Malvern Panalytical. Seating is limited, so don't wait, sign up early to get your seat. Breakfast and Lunch to be provided.


October 24 2018 - October 24 2018
09:30 - 15:30
(GMT-05:00) Eastern [US & Canada]
United States
Chubb Hotel & Conference Center, 800 Ridge Pike, Lafayette Hill, Pennsylvania, PA, USA, 19444
Event type:


Time Presentation
9.30-10.00am Arrival and Welcome

10.00 – 10.40 am Dr. Jonathan Mehtala
NTA for determination of virus and VLP aggregation state.

10.40 – 11.20am Customer Talk

11.20 – 12.00 am Dr. Stoyan Milev
DSC for studies of virus and VLP thermal stability.

12.00 – 1.00 pm Lunch

1.00 – 1.40 pm Dr. Arianna Biesso
Overview of Zetasizer Ultra for viral particle counting and sizing.

1.40 – 2.20 pm Customer Talk

2.20 – 3.00 pm Dr. Chris Cooper
Open discussion (Q+A) on current capabilities and future requirements in biophysical instrumentation.